Advik Laboratories is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company deals in a wide range of pharmaceuticals formulations like Tablets, Capsules and Dry Syrups, etc.Product Portfolio: a) WHO - GMP Certified Generic Products: Antibacterial Antiallergics Antifungals Analgesic Antipyretic Anti-inflammatory Anthelminthic Antihypertensive Antimalarial Antituberculotic…
MPS Pharmaa Limited has made public its unaudited financial results for the quarter ended June 30, 2025, through publications in major newspapers. This announcement provides stakeholders with crucial insight into the company's recent financial performance. Investors should review these results to assess the company's operational health and financial position for...
Mas Services Limited has confirmed that all securities received for dematerialization between April and June 2025 were processed—accepted or rejected—within 15 days of receipt. The physical certificates were duly mutilated and cancelled after verification, and the depositories’ names were updated as registered owners in the company’s records within the same...
MPS Pharmaa Limited has announced that it received one investor complaint during the quarter, which was resolved within the same period. There were no pending or unresolved complaints at the beginning or end of the quarter. This reflects the company’s effective handling of investor grievances, supporting shareholder confidence in its...
MPS Pharmaa Limited has submitted its Annual Secretarial Compliance Report confirming adherence to applicable SEBI regulations, with exceptions limited to delayed payment of Annual Listing Fees to BSE for multiple years. Due to these defaults, the company's shares have been suspended on BSE but continue to trade on a restricted,...
The company has announced a board meeting to consider the financial results for the quarter and half-year. This meeting is key for assessing recent operational performance and financial health. Stakeholders should watch for updates on earnings and strategic decisions that could influence the company’s trajectory and investor sentiment.
